Goldman Sachs analyst Adam Hotchkiss expressed expectations on Vertex, Inc. (NASDAQ:VERX) ahead of its first Investor Day as ...

Vertex Pharmaceuticals Incorporated VRTX stock has plunged 25.3% this year so far against the industry’s 5.4% increase. VRTX ...

The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its ...

Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success, says Dr Michael Tubbs ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Most of the focus in generative AI has been on text-based interfaces used to generate text, images, and more. The next wave ...

Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...

Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a ...

Vertex Minerals Limited (ASX:VTX) (OTCMKTS:VTXXF) is pleased with its achievements in the half-year to 31 December 2024 in pursuit of Vertex's st ...

KING OF PRUSSIA, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) today announced that it will host an Investor Day on Wednesday, March 19, in Philadelphia, PA. The event will ...

Google announced to integrate Chirp 3, the voice-based and HD text-to-speech models to its Vertex AI development platform ...